Regression testing minimization, selection and prioritization: a survey
Software Testing, Verification and Reliability · 2012-03 · 22 (2) · 67-120
DOI: 10.1002/stvr.430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Software Testing, Verification and Reliability, online erschienen am 11.10.2013. Verfasst von S. Yoo und 1 weiteren Autor:innen. Die Arbeit wurde bisher 235-mal zitiert (Crossref) und nennt 189 Literaturangaben.
Abstract (Originalsprache)
Regression testing is a testing activity that is performed to provide confidence that changes do not harm the existing behaviour of the software. Test suites tend to grow in size as software evolves, often making it too costly to execute entire test suites. A number of different approaches have been studied to maximize the value of the accrued test suite: minimization, selection and prioritization. Test suite minimization seeks to eliminate redundant test cases in order to reduce the number of tests to run. Test case selection seeks to identify the test cases that are relevant to some set of recent changes. Test case prioritization seeks to order test cases in such a way that early fault detection is maximized. This paper surveys each area of minimization, selection and prioritization technique and discusses open problems and potential directions for future research. Copyright © 2010 John Wiley & Sons, Ltd.
Zitieren
APA
Yoo, S., & Harman, M. (2012). Regression testing minimization, selection and prioritization: a survey. Software Testing, Verification and Reliability, 22(2), 67-120. https://doi.org/10.1002/stvr.430
Vancouver
Yoo S, Harman M. Regression testing minimization, selection and prioritization: a survey. Software Testing, Verification and Reliability. 2012;22(2):67-120. doi:10.1002/stvr.430
BibTeX
@article{Yoo2012,
author = {Yoo, S. and Harman, M.},
title = {Regression testing minimization, selection and prioritization: a survey},
journal = {Software Testing, Verification and Reliability},
year = {2012},
volume = {22},
number = {2},
pages = {67--120},
doi = {10.1002/stvr.430}
}
EUVIMED